Delivery Order SPE2DB22D1017-SPE2DB24FF5DC
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the supply of dextroamphetamine amphetamine 10 mg tablets. The $1,487.04 award has a completion date of February 26, 2024 and no set-aside designation was used. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
- This is a $1,173.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 10 mg tablets. It has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,653.71 order is for the supply of dextroamphetamine-amphetamine 10 mg tablets, to be delivered by January 30, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide 4,563,690,617 units of the pharmaceutical product dextroamphetamine-amphetamine 10 mg tablets. The $1,053.32 delivery order has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA worth up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,388.90 contract is for the supply of dextroamphetamine-amphetamine 15 mg tablets in 100-count bottles. The award has an ultimate completion date of July 18, 2024 and is not a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,351.44 order is for the supply of 4,564,135,160 tablets of dextroamphetamine-amphetamine 10 mg, with an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,695.98 contract is for the delivery of 20 mg dextroamphetamine-amphetamine tablets in 100-count packages. The contract does not have a set-aside designation and the period of performance runs through January 10, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10 mg tablets of the prescription drug dextroamphetamine-amphetamine. The $2,518.07 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of dextroamphetamine-amphetamine 5 mg tablets. The $1,017.84 firm-fixed-price contract has an ultimate completion date of October 9, 2024. It is not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,606.35 order is for the supply of 4,563,681,491 tablets of the drug dextroamphetamine 5 mg. The order has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has no designated set-aside status. Amerisourcebergen...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5DCDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical and healthcare company AmerisourceBergen Corporation. The $1,526.76 contract is for the delivery of 4564128975 units of the pharmaceutical product dextroamphetamine-amphetamine 10 mg tablets in 100-count packages. The award has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Firm fixed price task orders issued under this IDC enable AmerisourceBergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/1/24 |